مباشر

FierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filing PharmaVoiceWhy ivermectin is in the limelight again Clinical OMICsPhilippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders LabiotechEight in vivo CAR T biotechs to follow closely FierceBiotech'Biopharma ecosystem is back to full health,' fueled by M&A: PwC FierceBiotechJazz, AbCellera strike TCE discovery and development deal worth up to $792M per drug Endpoints NewsJazz turns to AbCellera for T cell engagers in up to $4.1B partnership Endpoints NewsSpot Bio launches with $40M to study mRNA therapy for muscular dystrophy Endpoints NewsTriveni Bio raises $65M ahead of upcoming readouts on eczema drugs CellCellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology CellA CRISPR knockout mouse library for functional genomics in influenza research Endpoints NewsMigraine biotech Vedana Therapeutics makes its debut with $46M Series A

Cell ١٧ يونيو ٢٠٢٦

Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology

Publication date: Available online 16 June 2026 Source: Cell Author(s): Yuchen Li, Zhe Li, Ryan Quinton, Yuanfeng Ji, Xiaoming Zhang, Jinxi Xiang, Xiyue Wang, S...

Publication date: Available online 16 June 2026 Source: Cell Author(s): Yuchen Li, Zhe Li, Ryan Quinton, Yuanfeng Ji, Xiaoming Zhang, Jinxi Xiang, Xiyue Wang, Sen Yang, Feyisope Eweje, Yijiang Chen, Xiangde Luo, Yuanyuan Li, Jonathan Mulholland, Siwei Chen, Colin Bergstrom, Ted Kim, Francesca Maria Olguin, Sierra Willens, Steven H. Lin, Jeffrey J. Nirschl